CVS HEALTH CORPORATION (CVS) capitalization

Current snapshot

Market Cap
$91.64B
1.28B shares × $71.82 · as of last filing 2026-03-31
Net Worth
$77.46B
Stockholders' equity · 2026-03-31
Enterprise Value
$155.60B
Market cap + debt − cash
Net Debt
$63.96B
Debt $75.77B − Cash $11.80B

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $100.87B
FY'24 2024-12-31 $56.65B
FY'23 2023-12-31 $101.86B
FY'22 2022-12-31 $123.29B
FY'21 2021-12-31 $137.10B
FY'20 2020-12-31 $89.75B
FY'19 2019-12-31 $96.95B
FY'18 2018-12-31 $68.40B
FY'17 2017-12-31 $74.24B
FY'16 2016-12-31 $85.14B
FY'15 2015-12-31 $110.09B
FY'14 2014-12-31 $112.59B
FY'13 2013-12-31 $87.74B
FY'12 2012-12-31 $61.89B
FY'11 2011-12-31 $54.93B
FY'10 2010-12-31 $47.88B
FY'09 2009-12-31 $46.70B
FY'09 2008-12-31 $42.22B
FY'09 2007-12-29 $54.88B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $91.86B
Q4'25 2025-12-31 $100.87B
Q3'25 2025-09-30 $95.67B
Q2'25 2025-06-30 $87.60B
Q1'25 2025-03-31 $85.64B
Q4'24 2024-12-31 $56.56B
Q3'24 2024-09-30 $79.17B
Q2'24 2024-06-30 $74.36B
Q1'24 2024-03-31 $101.06B
Q4'23 2023-12-31 $101.70B
Q3'23 2023-09-30 $90.07B
Q2'23 2023-06-30 $88.97B
Q1'23 2023-03-31 $95.93B
Q4'22 2022-12-31 $121.15B
Q3'22 2022-09-30 $125.41B
Q2'22 2022-06-30 $122.40B
Q1'22 2022-03-31 $134.41B
Q4'21 2021-12-31 $136.38B
Q3'21 2021-09-30 $112.78B
Q2'21 2021-06-30 $110.72B
Q1'21 2021-03-31 $99.45B
Q4'20 2020-12-31 $89.47B
Q3'20 2020-09-30 $76.80B
Q2'20 2020-06-30 $85.37B
Q1'20 2020-03-31 $77.84B
Q4'19 2019-12-31 $96.73B
Q3'19 2019-09-30 $82.31B
Q2'19 2019-06-30 $70.95B
Q1'19 2019-03-31 $70.22B
Q1'19 2019-01-01
Q4'18 2018-12-31 $84.85B
Q3'18 2018-09-30 $80.45B
Q2'18 2018-06-30 $65.51B
Q1'18 2018-03-31 $63.39B
Q4'17 2017-12-31 $73.52B
Q3'17 2017-09-30 $82.95B
Q2'17 2017-06-30 $82.39B
Q1'17 2017-03-31 $81.25B
Q4'16 2016-12-31 $83.72B
Q3'16 2016-09-30 $95.49B
Q2'16 2016-06-30 $102.92B
Q1'16 2016-03-31 $114.00B
Q4'15 2015-12-31 $107.64B
Q3'15 2015-09-30 $108.15B
Q2'15 2015-06-30 $118.72B
Q1'15 2015-03-31 $117.25B
Q4'14 2014-12-31 $109.79B
Q3'14 2014-09-30 $92.64B
Q2'14 2014-06-30 $88.48B
Q1'14 2014-03-31 $89.08B
Q4'13 2013-12-31 $84.45B
Q3'13 2013-09-30 $69.58B
Q2'13 2013-06-30 $70.67B
Q1'13 2013-03-31 $68.24B
Q4'12 2012-12-31 $59.52B
Q3'12 2012-09-30 $61.69B
Q2'12 2012-06-30 $60.14B
Q1'12 2012-03-31 $58.64B
Q4'11 2011-12-31 $52.93B
Q3'11 2011-09-30 $45.01B
Q2'11 2011-06-30 $51.26B
Q1'11 2011-03-31 $47.05B
Q4'10 2010-12-31 $47.39B
Q3'10 2010-09-30 $43.05B
Q2'10 2010-06-30 $40.14B
Q1'10 2010-03-31 $51.04B
Q4'09 2009-12-31 $44.80B
Q3'09 2009-09-30 $51.64B
Q2'09 2009-06-30 $46.91B
Q1'10 2009-03-31 $40.38B
Q4'09 2008-12-31 $41.27B
Q3'09 2008-09-27 $51.41B
Q2'09 2008-06-28 $58.41B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (CVS CIK 0000064803), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

OBIO

Orchestra BioMed Holdings, Inc.

WYY

WidePoint Corporation

ESS

ESSEX PROPERTY TRUST, INC.